Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.
about
Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignNew hepatitis C virus drug discovery strategies and model systemsSpecific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus.Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients.Characterization of cellular and humoral immune responses after IBV infection in chicken lines differing in MBL serum concentration.Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.Relationship of serum mannose-binding lectin levels with the development of sepsis: a meta-analysis.Complement-mediated neutralization of dengue virus requires mannose-binding lectinThe role of humoral innate immunity in hepatitis C virus infection.Rheumatoid factor, complement, and mixed cryoglobulinemia.Human lectins and their roles in viral infections.Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin-Mediated Neutralization.Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system.Mannose-binding lectin in chronic hepatitis C in children.Mannan binding lectin-associated serine protease 1 is induced by hepatitis C virus infection and activates human hepatic stellate cells.The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.Technical considerations for the generation of novel pseudotyped viruses
P2860
Q26801759-CFF33C5E-510D-4E2D-AE21-18CFDB318903Q26851159-9A399A0F-FE6F-4145-9098-99270F50506CQ34438382-D9E998EB-90D3-433F-8FFA-F85B0D9FE8F0Q34544492-B1BB5F66-E4A4-4780-BC79-03B86060335FQ34652546-0AD0E5D1-C419-469A-908B-A2201A0B874CQ35210857-06690408-0F1F-4F1A-9BD8-E58268437456Q35342497-A521E5B2-70B0-4860-A64A-55B32C850A78Q35607988-6E20213D-EBA9-47E2-AA9C-1AFAEE8AED47Q37987129-89EB0CC7-6941-4658-AF11-0D79BD489EFFQ38041549-B7107B34-55CF-4CF8-B5F1-3F4AF4A4ED16Q38340871-8F579807-4443-4F1A-A7E7-6C6CADE5F473Q38734919-143E17A2-1A91-47C6-B427-CA97FDC84B2AQ38738490-15A05682-7329-4AE4-ABC5-7519B65F13F7Q41751876-573DBD4E-C71E-477E-888B-4B9AE31EB196Q42284805-753BCEBE-C774-4C34-8EFF-06FAA2985741Q55130392-74BCE07D-B571-4E48-97D1-99BA3B670101Q57275154-6A92DAD0-D914-422A-816E-C87B4A0ED1DC
P2860
Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Specific interaction of hepati ...... g lectin inhibits virus entry.
@en
Specific interaction of hepati ...... g lectin inhibits virus entry.
@nl
type
label
Specific interaction of hepati ...... g lectin inhibits virus entry.
@en
Specific interaction of hepati ...... g lectin inhibits virus entry.
@nl
prefLabel
Specific interaction of hepati ...... g lectin inhibits virus entry.
@en
Specific interaction of hepati ...... g lectin inhibits virus entry.
@nl
P2093
P2860
P50
P1433
P1476
Specific interaction of hepati ...... ng lectin inhibits virus entry
@en
P2093
Ania M Owsianka
Arvind H Patel
James N Arnold
Kristelle S Brown
Michael J Keogh
Richard Adair
Robert B Sim
P2860
P2888
P304
P356
10.1007/S13238-010-0088-9
P577
2010-07-29T00:00:00Z